This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Inter Parfums (IPAR) Looks Solid, Gains More Than 35% in 6 Months
by Zacks Equity Research
Inter Parfums (IPAR) has been gaining on constant product launches and strategic partnerships. The company's 2021 guidance looks encouraging.
United Natural (UNFI) Stock Tumbles Despite Q3 Earnings Beat
by Zacks Equity Research
United Natural's (UNFI) third-quarter fiscal 2021 results reflect lower top and bottom line due to weakness across almost all channels.
Campbell (CPB) Q3 Earnings & Sales Lag Estimates, EPS View Cut
by Vrishali Bagree
Campbell Soup's (CPB) third-quarter fiscal 2021 results reflect soft earnings and sales. Comparisons with year-ago period's demand surge and rising cost inflation hurt the company.
PepsiCo's (PEP) Frito-Lay to Expand Plant Capacity in Rosenburg
by Zacks Equity Research
PepsiCo's (PEP) Frito-Lay is expanding plant capacity at its Rosenburg facility and adding manufacturing lines for Funyuns and tortilla chips, which are expected to be completed by 2023.
Philip Morris (PM) Firm on 2021 View, Duty-Free Unit Weak
by Zacks Equity Research
Philip Morris (PM) continues to expect adjusted earnings in the range of $5.95-$6.05 for 2021. The company does not expect any near-term recovery in the duty-free business.
Flowers Foods (FLO) Buys Koffee Kup Bakery's Assets to Aid Growth
by Zacks Equity Research
Flowers Foods (FLO) acquires assets of Koffee Kup Bakery, Inc. to expand presence in the key Northeast market.
SpartanNash's (SPTN) Q1 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
SpartanNash (SPTN) posts mixed results for the first quarter of 2021. The company's segmental sales decline weighs on the overall top line.
The J.M. Smucker (SJM) Q4 Earnings Top Estimates, Sales Down
by Zacks Equity Research
The J.M. Smucker's (SJM) fourth-quarter fiscal 2021 results reflect lower sales and earnings thanks to weakness across most segments. Nevertheless, sustained demand for at-home food was an upside.
Here's Why You Must Add Newell Brands (NWL) to Your Portfolio
by Zacks Equity Research
Although cost woes remain concerns, robust consumption patterns, higher demand and a solid online show are likely to aid Newell Brands (NWL).
Tyson Foods (TSN) Offers Plant-Based Products in Asia Pacific
by Zacks Equity Research
Tyson Foods' (TSN) is launching a range of plant-based products in chosen retail markets and digital platforms in Asia Pacific under First Pride brand.
Pilgrim's Pride (PPC) Gains on Capacity Growth, Mexico Unit
by Zacks Equity Research
Pilgrim's Pride (PPC) gains from capacity expansions for key products. Also, solid operations in Mexico and revival of market conditions in the United States are upsides.
Mondelez's (MDLZ) Chipita Buyout to Boost Presence in Europe
by Zacks Equity Research
Mondelez (MDLZ) announces a deal to acquire the producer of sweet and salty snacks, Chipita, which will boost its presence in Central and Eastern Europe.
Medifast (MED) Looks Appetizing, OPTAVIA Solution a Key Upside
by Zacks Equity Research
Medifast (MED) has been benefiting from its OPTAVIA lifestyle solution and coaching support system. Additionally, the company has been speeding up its long-term supply-chain efforts.
Tyson Foods' (TSN) Retail Business Gains on Strong Demand
by Zacks Equity Research
Tyson Foods (TSN) is witnessing sturdy demand in the retail channel. The company's rich brand portfolio and efforts to boost operational efficiency are encouraging.
Kellogg (K) Gains More Than 10% in 3 Months: Will Growth Stay?
by Zacks Equity Research
Kellogg Company (K) looks well placed on the back of high demand for packaged foods amid the pandemic. Certainly, the company's brand strength has been a driver.
What Makes Nomad Foods (NOMD) a New Buy Stock
by Zacks Equity Research
Nomad Foods (NOMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Nomad Foods (NOMD) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Nomad Foods (NOMD) delivered earnings and revenue surprises of 21.74% and 2.45%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Beyond Meat (BYND) Queued for Q1 Earnings: Factors to Note
by Zacks Equity Research
Beyond Meat's (BYND) first-quarter 2021 results are likely to reflect softness in the foodservice business due to lower traffic and curbs on foodservice location operations.
TreeHouse Foods (THS) Queued for Q1 Earnings: What's in Store?
by Zacks Equity Research
TreeHouse Foods' (THS) first-quarter 2021 results are likely to reflect high costs and a soft Food Away From Home business. Nevertheless, strong retail demand is an upside.
Hain Celestial (HAIN) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Hain Celestial's (HAIN) robust transformation plan along with supply-chain productivity initiatives and rationalization efforts has likely boosted third-quarter fiscal 2021 earnings.
Here's How Monster Beverage (MNST) is Placed for Q1 Earnings
by Zacks Equity Research
Monster Beverage's (MNST) Q1 results are likely to reflect gains from the energy drinks category as well as momentum in e-commerce. The pandemic-led headwinds are likely to have been concerning.
Factors Likely to Influence AB InBev's (BUD) Earnings in Q1
by Zacks Equity Research
Strong volume trends, strength in off-premise and robust e-commerce growth are expected to have boosted AB InBev's (BUD) top line in Q1. Soft margins, owing to higher costs, remain deterrents.
Here's How Medifast (MED) is Placed Ahead of Q1 Earnings
by Zacks Equity Research
Strength in the OPTAVIA lifestyle solution and coaching support system have most likely aided Medifast's (MED) first-quarter 2021 performance.
Nomad Foods (NOMD) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Nomad Foods (NOMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Clorox (CLX) Queues Up For Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Clorox (CLX) witnesses manufacturing and logistics costs. These along with higher selling and administrative costs might have hurt the bottom line in third-quarter fiscal 2021.